Chronic Recurrent Multifocal Osteomyelitis: A Case Report with Atypical Presentation. by Figueiredo, M et al.
75
Chronic Recurrent Multifocal Osteomyelitis: A Case Report 
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Abstract
Introduction: Chronic recurrent multifocal osteomyelitis (CRMO) is a rare autoinflammatory condition. The clinical picture 
consists of sterile osteomyelitis, typically with multiple-site lesions in the metaphysis of long bones and not uncommonly, symmetrical 
bone involvement. It is a poorly understood entity, whose prognosis, etiology and ideal treatment are still controversial. The authors 
report a case of unifocal presentation with an atypical location.
Case Report: A previously healthy 12-year-old Caucasian girl came to our institution due to progressive pain on her left thigh for the previous 
3 months. The initial X-ray showed a permeative, diaphyseal lesion of her left femur, with marked periosteal reaction. The differential initially 
included Ewing’s sarcoma, osteosarcoma, subacute osteomyelitis, and Langerhans cell histiocytosis. Needle and open biopsies demonstrated 
the presence of chronic inflammatory infiltrate, with fibrosis, but no signs of neoplastic disease. Serologic and microbiological studies failed 
to demonstrate an infectious etiology. The patient was treated with nonsteroid anti-inflammatories, corticosteroids, and bisphosphonates 
for 6 months. Although no antibiotics were employed, the patient showed clinical and radiological improvement, at 18-month follow-up.
Conclusions: CRMO is a rare condition, and the absence of specific features constitutes a diagnostic challenge. A  high level of 
suspicion is paramount to avoid unnecessary biopsies and repeated antibiotic regimens. Unifocal presentation of this disease, atypical 
locations, and absence of recurrence have all been previously reported, with the evidence pointing to a shared etiological process with 
no distinction being made between these variants. For this reason, the authors believe that the term “nonbacterial osteomyelitis” 
might be a more all-embracing designation.
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Introduction
Chronic recurrent multifocal osteomyelitis (CRMO) is a non-
infectious inflammatory condition of the bone of unknown etiology. Its 
reported incidence is 1/1.000.000 and affects more women, at a ratio 
of approximately 2:1-5:1 [1, 2]. The currently used term, CRMO, was 
proposed by Bjorksten, but references to chronic multifocal symmetric 
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What to Learn from this Article?
Awareness of CRMO/nonbacterial osteomyelitis is paramount to establish an early diagnosis and provide an 
individualized treatment, avoiding unnecessary procedures.
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osteomyelitis and others are common [3]. It is a pediatric condition 
sharing a few common features with the synovitis, acne, pustulosis, 
hyperostosis, and osteitis syndrome seen in adults; some investigators 
suggest that CRMO represents a subgroup of this entity [4].
Patients are typically children or adolescents, presenting with bone pain, 
which may concur with tenderness, swelling, and other inflammatory 
signs. Symptoms are typically intermittent, lasting weeks to months, after 
which they subside and relapse. The mean duration of active disease is 
between 2 and 5 years but has been reported to be as high as 20 years [2]. 
Factors identified as duration predictors are younger age, number of 
lesions at presentation, and total number of lesions [2].
The involvement is more frequent at the metaphyses of the long bones 
and is often symmetrical, although other uncommon skeletal sites have 
also been described [5, 6]. Radiologically, there is an osteolytic lesion 
with early sclerosis and hyperostosis, though sclerosis and hyperostosis 
are suggested to be involved in the natural bone reparative reaction. With 
enough time, lamellated periosteal reaction occurs. Some lesions might be 
asymptomatic and are incidentally found on radiographs of other regions. 
Regional magnetic resonance imaging (MRI) typically shows marrow 
edema and whole body MRI or bone scintigraphy can help in detecting 
asymptomatic lesions and assess plurality, which helps in excluding other 
diseases.
Histologically, there is nonspecific osteitis with an inflammatory infiltrate, 
consisting of polymorphonuclear and giant cells. Bone resorption and 
reactive bone formation typically follows, with sclerosis and lymphocytic 
infiltration. At even later stages, there may be complete resolution of this 
infiltrate, and only fibrosis with non-arranged, immature bone is to be 
found.
It has been proven to be a non-benign disease in the long term, with 
persistent pain and bone deformity as the most common complaints. 
Premature epiphyseal fusion with short stature or limb length discrepancy 
and long bone deformity has been reported in patients with immature 
skeletons. Quality of life is affected, with withdrawal from sports, 
school interruption, and job impairment seen in a range of 7-75% of the 
patients [2, 7].
We present the case of a young patient with unifocal diaphyseal 
presentation of this disease.
Case Report
A 12-year-old Caucasian girl presented to our clinic with a history of 
worsening the left thigh pain for the last 3  months. She was previously 
healthy, with no history of trauma, and neither she nor her mother could 
recall any triggering factor for the onset of the pain. There was a decrease 
in the appetite but no weight loss or fever. At the time of initial evaluation, 
she was experiencing pain throughout the day and night. She quantified 
her pain as 8 out of 10 in the visual analog scale (VAS). She had stopped 
all physical activities completely and was walking with the aid of crutches. 
The thigh was slightly swollen and was very tender to light touch, with 
quadriceps atrophy, but no increase in local temperature. The active and 
passive ranges of motion of the hip and the knee were globally decreased, 
due to severe pain. The rest of the clinical examination was normal, in 
particular, no foci of infection were apparent elsewhere in the body, and 
no skin conditions were detected. She had no pets, no history of travel, 
and her familiar history was unremarkable. Her initial blood work revealed 
only a slight increase in the erythrocyte sedimentation rate (24 mm/h).
The initial radiographs of the left thigh showed a proximal third diaphyseal 
lesion of the left femur with aggressive appearance (Fig. 1). It was a centro-
medullary, permeative lesion with ill-defined margins and a wide zone 
of transition. There was cortical thickening with areas of scalloping and 
cortical erosion, and circumferential onion skin appearance denoting 
moderately aggressive periosteal reaction. No Codman’s triangle or 
sunburst appearance, indicating faster and more aggressive periostitis, 
were visible. MRI showed a 12-cm medullary lesion with hyposignal in 
T1-weighted and hypersignal in fat-suppressed T2-weighted images, 
with medullary enhancement after contrast injection. There were areas 
of cortical disruption, extensive periosteal reaction and perilesional soft 
tissue edema, but no soft tissue invasion (Fig. 2 and 3).
Figure  1: Anteroposterior radiograph 
of the left thigh showing a proximal 
third diaphyseal lesion of the left femur. 
Note the aggressive features represented 
by the ill-defined margins with a wide 
zone of transition, cortical erosion and 
circumferential onion skin appearance 
denoting moderately aggressive periosteal 
reaction.
Figure 2: Short tau inversion recovery-weighted coronal section of both thighs, 
showing hypersignal in the medullary canal at the left femoral diaphysis, with 
marked periosteal reaction and peripheral soft tissue hypersignal.
www.jocr.co.in
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Needle biopsy was performed 2  weeks after the initial presentation for 
microbiological and pathological evaluation, and no evidence was found 
for infection or tumor (Fig. 4). Serology for Bartonella, Brucella, Salmonella, 
Tularemia, Coxiella and Mycobacterium tuberculosis were negative. The 
patient was kept under observation by the tumor team. She was taking 
acetaminophen for pain relief and the clinical picture remained unaltered 
for the next month. A  second biopsy was obtained through a mini-open 
approach again, showing no evidence of tumor or infection. At this point, the 
diagnosis of CRMO was considered, and a scintigram was obtained, which 
showed unifocal heterogeneous uptake at her left femoral diaphysis, with no 
other suspicious hot spots. She was then started on 250 mg naproxen t.i.d. 
with 20 mg omeprazole, 10 mg prednisone daily and a single dose of 30 mg 
pamidronate. Her VAS score showed initial improvement, from 8 to 3, with 
pain affecting her only on weight-bearing and no pain at night.
She was maintained on this regimen for 6 months. During this period, she 
also experienced isolated episodes of pain on her right thigh and on her left 
ankle, with no abnormal findings on the radiographs. After an 18-month 
follow-up, she demonstrated progressive improvement of her left thigh 
pain that occasionally recurred with less and less frequency. Although she 
was walking without crutches, she was still restricted from physical activity.
Discussion
CRMO is a rare disease and its diagnosis is difficult due to the lack of 
specific features. Most recent evidence suggests an autoinflammatory 
origin, but the etiology is yet to be established conclusively [8]. CRMO 
has been hypothesized to be the response to an undetected infection. 
Some authors reported cases of infectious multifocal osteomyelitis due to 
facultative bacteria, which could not be detected by the aerobic-seeking 
culture media used in regular laboratory analyses [9]. Other authors 
reported cases whose biopsies were positive for commensal cutaneous 
bacteria such as Staphylococcus epidermidis and Propionibacterium acnes, 
but these are generally believed to be the result of culture contamination. 
In our case, there were no detectable risk factors, and microbiological or 
serological evidence indicating an infectious agent.
Our patient did not have a history of autoimmune conditions, 
including peripheral arthritis, Crohn’s disease, psoriasis, or 
spondyloarthropathies [10].
Being an exclusion diagnosis, the clinician has first to rule out malignancy 
(Ewing’s sarcoma, osteosarcoma, and lymphoma), Langerhans cell 
histiocytosis, osteoma osteoid, and subacute osteomyelitis. The finding 
of multiple-site involvement surely helps the clinician in establishing 
the diagnosis of CRMO. However, when the finding involves a single 
or atypical (e.g.  diaphyseal) lesion, the clinician is confronted with a 
diagnostic challenge. Manson [11] proposed the diagnostic criteria that 
are shown in Table 1, where plurality of lesions is an important feature. 
However, as in our patient, other case series also have shown patients 
where a single lesion was detected. In Girschick’s series of 30  patients, 
for example, 10% had unifocal recurrent form of disease and 30% 
had a unifocal single time episode [7]. For this reason, we agree with 
Cimolai et al. and Girschick et al. [3, 7] that the term CRMO might be 
too restrictive, assuming plurality/recurrence of lesions as sine qua non 
features. Other authors use the term nonbacterial osteomyelitis (NBO), 
which we believe might be a more all-encompassing term [12]. Jansson 
et al. proposed different diagnostic criteria for NBO (Table 2) [10], which 
our patient met.
The optimal treatment for this disease is still under debate. The first-line 
treatment for CRMO is nonsteroidal anti-inflammatory drugs, reported 
to be effective in 80% of patients for symptomatic relief [7]. In non-
responders, glucocorticoids have shown to be effective [7, 10, 11].
Anti-tumor necrosis factor α (TNFα) drugs have been used with good 
results [13]. TNFα is a proinflammatory cytokine and was found to be 
elevated in CRMO patients [10, 14]. We decided to postpone the need for 
biological therapy unless the patient experienced no improvement with 
first-line drugs.
Approximately 80% of patients, reviewed from the available case reports 
and series, showed improvement with bisphosphonates [13]. The 
radiological decrease in size was also observed in some lesions. The action 
of these drugs is not fully understood, but it appears to be linked to a 
decrease in lesion expansion, a phenomenon that depends on osteoclastic 
activity at the edge of the lesion. However, the prompt symptomatic 
Figure  3: T1-weighted axial section of both thighs, showing global muscular 
atrophy at the left, with cortical thickening of the left femur and abnormal 
hyposignal in the medullary canal. Some erosion is visible in the posterior cortex 
but without soft tissue invasion.
Table 1: Proposed criteria for CRMO diagnosis
Multifocal bone lesions
Remission and exacerbation of signs and symptoms for at least 6 months
Lack of an identifiable cause
Lack of response to antibiotics for at least 1 month
Chronic, nonspecific inflammation consisting of lymphocytes, plasma cells, and 
histiocytes at histopathologic examination
Adapted from Manson et al. CRMO: Chronic recurrent multifocal osteomyelitis
Figure 4: Bone needle-biopsy initially performed. (a) Islands of newly-formed 
osteoid, alternating with areas of fibrosis (×10). (b) Fibrosis, with occasional 
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relief experienced by some patients also suggests a role for a non-
anatomical action, probably linked to the anti-inflammatory properties 
of bisphosphonates. In our patient, significant pain relief was obtained 
after beginning bisphosphonate therapy. However, it is hard to establish 
causality, since other drugs were also started simultaneously.
Conclusion
CRMO is a rare disease and much remains to be known about the ideal 
management of this condition. Diaphyseal and/or unifocal lesions 
might occur, and the use of more broad criteria has increased diagnosis 
sensitivity. Awareness about this disease and its variants is paramount 
to prevent unnecessary repeated biopsies and antibiotic regimens. 
Prospective studies with a control group would help in identifying the 
optimal treatment and the effects of the drug classes discussed in this 
text.
Clinical Message
Chronic recurrent multifocal osteomyelitis can present with unifocal 
lesions, atypical locations or absence of recurrence. A  high level of 
suspicion is paramount to avoid unnecessary biopsies and repeated 
antibiotic regimens. The term “nonbacterial osteomyelitis” might be a 
more all-embracing designation.
Table 2: Proposed major and minor diagnostic criteria of NBO. 
NBO is confirmed by two major criteria or one major and three 
minor criteria
Major diagnostic criteria Minor diagnostic criteria
1. Radiologically proven 
osteolytic/-sclerotic bone lesion
1. Normal blood count and good 
general state of health
2. Multifocal bone lesions 2. CRP and ESR 
mildly-to-moderately elevated
3. Palmoplantar pustulosis or psoriasis 3. Observation time longer than 
6 months
4. Sterile bone biopsy with evidence of 
inflammation and/or fibrosis, sclerosis
4. Hyperostosis
5. Associated with other 
autoimmune diseases apart 
from palmoplantar pustulosis or 
psoriasis
6. Grade I or II relatives with 
autoimmune or auto-inflammatory 
disease, or with NBO
Adapted from Jansson et al. NBO: Nonbacterial osteomyelitis, ESR: Erythrocyte sedimentation rate, 
CRP: C-reactive protein
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